Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease

Long-Term Response Rates to Infliximab Therapy for Crohn’s Disease in an Outpatient Cohort

(2016) Christopher W Teshima et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Safety of infliximab in 10 years of clinical practice

(2011) Sarah OʼDonnell et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

(2010) David S. Kotlyar et al.   Clinical Gastroenterology and Hepatology

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn’s Disease

(2009) Joel R Rosh et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Serum sickness, encephalitis and other complications of anti-cytokine therapy

(2009) Séverine Vermeire et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Infliximab in clinical routine: experience with Crohnʼs disease and biomarkers of inflammation over 5 years

(2009) Maria H. Lönnkvist et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Adalimumab safety in global clinical trials of patients with Crohnʼs disease

(2009) Jean-Frédéric Colombel et al.   INFLAMMATORY BOWEL DISEASES

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2009) J.F. Rahier et al.   Journal of Crohns & Colitis

Efficacy of adalimumab for the management of Inflammatory Bowel Disease in the Clinical Setting

(2009) Matthew W. Trinder et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Efficacy and complications of adalimumab treatment for medically-refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004-2008)

(2008) G. T. HO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Infliximab for Inflammatory Bowel Disease in Denmark 1999–2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality

(2008) Sarah Caspersen et al.   Clinical Gastroenterology and Hepatology

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT